Cystic fibrosis pulmonary disease is characterized by chronic and recurrent infection, airway inflammation, bronchiectasis and progressive obstructive lung physiology. Advances in the treatment of ...
Prepared off-label from commercially available intravenous products. NA: Not available. Cystic fibrosis (CF) pulmonary disease is characterized by chronic and recurrent infection, and airway ...
One of the frustrating things about a urinary tract infection (UTI) is that it interferes with sex. It is one thing when it happens every once in a while; it's another when it becomes an ongoing, ...
A drug that patients with recurrent and chronic urinary tract infections (UTI) currently spend over £500 a year on privately will become widely available via the NHS next month, i can reveal.
Get detailed information on Amikacin, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated prescription ...
Get detailed information on Ceftazidime, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated prescription ...
For the first time, the British Thoracic Society (BTS), National Institute for Health and Care Excellence (NICE) and the Scottish Intercollegiate Guidelines Network (SIGN) have collaborated to develop ...
People with cystic fibrosis (CF) have higher chloride levels due to a genetic defect that disrupts this process. The sweat test is usually recommended for newborns with abnormal screening results ...
Cystic Fibrosis (CF) is one such condition that has seen significant medical advancements with increased life expectancy but continues to overlook aspects of care including sexual and reproductive ...
Cystic fibrosis (CF) is a genetic condition that affects the production of mucus in the body. Individuals with CF tend to have thick, sticky mucus that can clog airways, creating a favorable ...
Nov 4 (Reuters) - Vertex Pharmaceuticals (VRTX.O), opens new tab raised its annual revenue forecast on Monday after it beat third-quarter estimates on demand for its cystic fibrosis (CF ...